Search for: "L MARTINEZ"
Results 421 - 440
of 465
Sorted by Relevance
|
Sort by Date
20 Jun 2014, 10:12 am
ROBERT L. [read post]
3 Jan 2021, 3:07 pm
Audits of Respiratory (CPT Code 87633) / Gastro (CPT Code 87507) Panels are Ongoing. [read post]
19 Dec 2010, 9:37 pm
L. [read post]
28 Dec 2020, 9:01 pm
As outlined in Martinez v. [read post]
20 Jul 2023, 2:30 am
My first major influence is Lucas Martinez, who is currently our CEO at Talent.com. [read post]
8 Mar 2017, 11:28 am
L'Avvocato delle Donne (1996). [read post]
8 Mar 2017, 11:28 am
L'Avvocato delle Donne (1996). [read post]
8 Nov 2017, 7:40 am
Martinez, Justice, Irene Rios, Justice.MEMORANDUM OPINIONREBECA C. [read post]
8 Nov 2017, 7:40 am
Martinez, Justice, Irene Rios, Justice.MEMORANDUM OPINIONREBECA C. [read post]
12 Jan 2011, 2:00 am
Martinez v. [read post]
19 Jan 2008, 11:58 am
In this appeal, L. [read post]
24 Feb 2011, 8:47 am
Oliver, Jason L. [read post]
29 Mar 2013, 2:00 pm
Bugay & Craig L. [read post]
16 Sep 2017, 10:26 am
Martinez, No. 01-07-00363-CV, 2008 WL 5392023, at *2 n.4 (Tex. [read post]
9 Oct 2014, 9:12 am
Todd, “An Enduring Oddity: The Collateral Source Rule in the Face of Tort Reform, the Affordable Care Act, and Increased Subrogation,” 43 McGeorge L. [read post]
12 Jan 2015, 10:09 am
Attorney for the Eastern District of New York, including two years on the Enron Task Force, and received the Henry L. [read post]
6 Mar 2015, 12:53 pm
ARBITRABILITY OF HEALTH CARE LIABILITY CLAIMS IN TEXAS: FAA PREEMPTION AND MFA REVERSE PREEMPTION IN THE MED-MAL CONTEXT In an opinion released today, the Texas Supreme Court holds that the federal law that accords states the right to regulate the business of insurance (McCarran-Ferguson Act) does not furnish an exception to the general principle that the FAA (Federal Arbitration Act) preempts the TAA (Texas Arbitration Act) and other state arbitration laws when the two conflict, where the… [read post]
20 Jul 2023, 1:25 am
By Richard T. [read post]
12 Jan 2017, 7:01 am
Amgen Inc. 15-1039 Issues: (1) Whether notice of commercial marketing given before Food and Drug Administration approval can be effective; and (2) whether, in any event, it is improper to treat Section 262(l)(8)(A) – the Biologics Price Competition and Innovation Act of 2009’s “Notice of commercial marketing” provision which states that a biosimilar applicant shall provide notice to the incumbent seller of the biological product “not later than 180 days before… [read post]
12 May 2012, 10:19 pm
Caroline Bettinger-López, University of Miami, EEUU30. [read post]